Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
AOD-9604 Dosing Protocol Published human research with AOD-9604 used oral and intravenous routes
This entry, however, requires a hormone known as insulin, which is produced by the pancreatic cells
Deploy a multi-channel engagement strategy that blends personal promotion, nonpersonal outreach, and consumer-driven campaigns
Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo
Clinically meaningful responses in insulin-resistant patients typically include a reduction in fasting insulin of 20-40% and an improvement in HOMA-IR within 8-12 weeks at therapeutic doses, though individual variability is wide [1]
The brand name reflects the FDA-approved indication
US$ 20.74
US$ 24.77
US$ 20.82
US$ 24.54
US$ 20.56
US$ 20.03
US$ 28.24
US$ 28.91
